Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 25, 2011
Grant Date -
Jun 4, 2009
app pub date -
Nov 25, 2008
filing date -
Nov 30, 2007
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to imidazo[1,5-a]quinoxaline derivatives having Formula IIa:to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10 (PDE10), as active compounds for treating central nervous system diseases of mammals, including humans.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully